The second PI(3,5)P2 binding site in the S0 helix of KCNQ1 stabilizes PIP2-at the primary PI1 site with potential consequences on intermediate-to-open state transition.

Dellin M; Rohrbeck I; Asrani P; Schreiber JA; Ritter N; Glorius F; Wünsch B; Budde T; Temme L; Strünker T; Stallmeyer B; Tüttelmann F; Meuth SG; Spehr M; Matschke J; Steinbicker A; Gatsogiannis C; Stoll R; Strutz-Seebohm N; Seebohm G

Research article (journal) | Peer reviewed

Abstract

The Phosphatidylinositol 3-phosphate 5-kinase Type III PIKfyve is the main source for selectively generated phosphatidylinositol 3,5-bisphosphate (PI(3,5)P2), a known regulator of membrane protein trafficking. PI(3,5)P2 facilitates the cardiac KCNQ1/KCNE1 channel plasma membrane abundance and therewith increases the macroscopic current amplitude. Functional-physical interaction of PI(3,5)P2 with membrane proteins and its structural impact is not sufficiently understood. This study aimed to identify molecular interaction sites and stimulatory mechanisms of the KCNQ1/KCNE1 channel via the PIKfyve-PI(3,5)P2 axis. Mutational scanning at the intracellular membrane leaflet and nuclear magnetic resonance (NMR) spectroscopy identified two PI(3,5)P2 binding sites, the known PIP2 site PS1 and the newly identified N-terminal α-helix S0 as relevant for functional PIKfyve effects. Cd2+ coordination to engineered cysteines and molecular modeling suggest that repositioning of S0 stabilizes the channel s open state, an effect strictly dependent on parallel binding of PI(3,5)P2 to both sites.

Details about the publication

JournalBiological Chemistry
Volume404
Issue4
Page range241-254
StatusPublished
Release year2023 (28/03/2023)
Language in which the publication is writtenEnglish
DOI10.1515/hsz-2022-0247
Link to the full texthttps://www.degruyterbrill.com/document/doi/10.1515/hsz-2022-0247/html
KeywordsPhosphatidylinositol 4,5-Diphosphate; KCNQ1 Potassium Channel; Binding Sites; Mutation; Cell Membrane

Authors from the University of Münster

Budde, Thomas
Institute of Physiology I (Neurophysiology)
Gatsogiannis, Christos
Center for Soft Nanoscience (SoN)
Glorius, Frank
Professur für Organische Chemie (Prof. Glorius)
Ritter, Nadine
Institut für Genetik von Herzerkrankungen (IfGH)
Schreiber, Julian Alexander
Professur für Pharmazeutische Chemie (Prof. Wünsch)
Seebohm, Guiscard
Department for Cardiovascular Medicine
Münster Graduate School of Evolution (MGSE)
Stallmeyer, Birgit Annemarie
Institut für Genetik von Herzerkrankungen (IfGH)
Strünker, Timo
Institut für Reproduktions- und Regenerationsbiologie
Strutz-Seebohm, Nathalie
Institut für Genetik von Herzerkrankungen (IfGH)
Temme, Louisa
Professur für Pharmazeutische Chemie (Prof. Wünsch)
Tüttelmann, Frank
Institute of Reproductive Genetics
Wünsch, Bernhard
Professur für Pharmazeutische Chemie (Prof. Wünsch)